Fluticasone (Flixotide Accuhaler) 50 mcg: Supply issue
The supplier is out of stock of the 50 mcg Flixotide Accuhaler (Pharmacode: 402958).
Affected product
The supplier is out of stock of the following:
- Chemical: Fluticasone
- Presentation: Powder for inhalation, 50 mcg per dose
- Brand: Flixotide Accuhaler
- Pharmacode: 402958
Schedule listing for fluticasone(external link)
This supply issue does not affect other strengths or presentations of fluticasone.
Alternatives
We have received clinical advice that the following may be suitable alternatives. We're sorry, we know having to change treatment because of a supply issue can be disruptive. Pharmac and suppliers work hard to avoid supply issues but we could not avoid it in this instance.
Fluticasone
The metered-dose inhaler (MDI) Flixotide may be an alternative for some people.
- Chemical: Fluticasone
- Presentation: Aerosol inhaler, 50 mcg per dose
- Brand: Flixotide
- Pharmacode: 2004887
Please consider providing a spacer with this product.
Budesonide
Prescribers could also consider:
- Chemical: Budesonide
- Presentation: Powder for inhalation, 100 mcg per dose
- Brand: Pulmicort Turbuhaler
- Pharmacode: 682128
Inhaler identification chart from Respiratory Foundation NZ [PDF](external link)
For people over 12 years old
For those over 12 years old, consider prescribing Symbicort.
Schedule listings for Symbicort(external link)
Asthma Foundation treatment guidance for people over 12 years old(external link)
General supply issue flyer for pharmacists
- General Supply Issue A5 Flier [PDF 112 KB]
Expected resupply late September 2025
The supplier expects the next shipment to arrive by the end of September. It may be another 1 to 2 weeks after that before the inhalers are available at pharmacies again.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)